Founded in 2017, The Silverstein Foundation for Parkinson's with GBA actively pursues and invests in cutting-edge research with the goal of discovering new therapies for the treatment of Parkinson's disease in glucocerebrosidase (GBA) mutation carriers. Our four goals are: - To raise awareness around Parkinson’s disease associated with GBA mutations and relevant clinical trials for mutation carriers; - To aggressively seek out new, cutting-edge therapeutic approaches to treating and preventing Parkinson’s in GBA mutation carriers; - To engage with clinicians, scientists and biotechnology companies to accelerate research and clinical trials in an effort to rapidly bring new therapeutic options to patients; - To raise the necessary funds to meet these goals.
| Website | http://www.silversteinfoundation.org |
| Employees | 8 (5 on RocketReach) |
| Founded | 2017 |
| Address | Ansonia Station, PO Box 237137, New York, New York 10023, US |
| Industry | Research Services |
| Keywords | Parkinson's Disease, New Therapies, Parkinson's Treatment, Therapeutic Research, Cutting Edge Therapies, Neurological Research, Drug Discovery, Research Funding, Rare Disease Research, Disease Treatment, Genetic Research, Clinical Research, Medical Research Funding, Foundation Funding, Medical Research, Philanthropic Funding, Nonprofit Research |
Looking for a particular The Silverstein Foundation employee's phone or email?
Vivian Liu is the Executive Director of The Silverstein Foundation.
5 people are employed at The Silverstein Foundation.
The Silverstein Foundation is based in New York, New York.